Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser:	S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Format:	Artikel
Sprache:	Russian
Veröffentlicht:	«FIRMA «SILICEA» LLC 2004-12-01
Schriftenreihe:	Российский кардиологический журнал
Schlagworte:	arterial hypertension metabolic syndrome cardioprotective effects rilmenidine
Online Zugang:	https://russjcardiol.elpub.ru/jour/article/view/2326

Ähnliche Einträge

EFFECT OF ANTIHYPERTENSIVE THERAPY WITH RILMENIDINE ON COGNITIVE FUNCTION IN ELDERLY HYPERTENSIVE PATIENTS
von: S. V. Nedogoda, et al.
Veröffentlicht: (2016-01-01)

ASSESSMENT OF RILMENIDINE EFFICIENCY IN PATIENTS WITH ARTERIAL HYPERTENSION WITH DETERIORATION OF DAILY PROFILE OF BLOOD PRESSURE
von: P. P. Tikhonov, et al.
Veröffentlicht: (2015-12-01)

Perspectives of decreasing individual cardiovascular risk in high- and very high risk patients with arterial hypertension, treated with rilmenidine
von: S. V. Nedogoda, et al.
Veröffentlicht: (2005-06-01)

Workplace arterial hypertension: potential of rilmenidine-based combination therapy
von: S. I. Drozdetsky, et al.
Veröffentlicht: (1970-01-01)

Rilmenidine treatment in hypertensive patients with cerebrovascular transient ischemic attacks
von: A. P. Kondrakhin, et al.
Veröffentlicht: (2005-10-01)

Rilmenidine therapy potential in pharmaceutical correction of endothelial dysfunction among women with arterial hypertension, Type 2 diabetes mellitus, and visceral obesity
von: E. V. Eliseeva, et al.
Veröffentlicht: (1970-01-01)

THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL
von: Y. R. Kasherininov, et al.
Veröffentlicht: (2016-01-01)

Autophagy and anti-inflammation ameliorate diabetic neuropathy with Rilmenidine
von: Mehmet Burak Yalçın, et al.
Veröffentlicht: (2023-12-01)

Rilmenidine Protects Against Joint Damage in MIA-induced Model of Osteoarthritis in Rats
von: Osman Kukula, et al.
Veröffentlicht: (2024-02-01)

Stimulation of mTOR-independent autophagy and mitophagy by rilmenidine exacerbates the phenotype of transgenic TDP-43 mice
von: Nirma D. Perera, et al.
Veröffentlicht: (2021-07-01)

Main results of the Russian trial «ALTAIR»
von: E. V. Shlyakhto, et al.
Veröffentlicht: (2006-02-01)

ARTERIAL HYPERTENSION IN YOUNG PEOPLE: EFFICACY OF SYMPATHOLYTIC THERAPY
von: N. N. Nikitina, et al.
Veröffentlicht: (2015-12-01)

Comparison in conscious rabbits of the baroreceptor-heart rate reflex effects of chronic treatment with rilmenidine, moxonidine, and clonidine
von: Monique L Parkin, et al.
Veröffentlicht: (2016-11-01)

Effects of centrally acting antihypertensive drugs on the microcirculation of spontaneously hypertensive rats
von: V. Estato, et al.
Veröffentlicht: (2004-10-01)

PHARMACEUTICAL CORRECTION OF VASCULAR DISTURBANCES IN PATIENTS WITH ARTERIAL HYPERTENSION
von: L. A. Khaisheva, et al.
Veröffentlicht: (2010-10-01)

Combined treatment of arterial hypertension: focus on calcium antagonist and ACE inhibitor combination
von: V. I. Makolkin
Veröffentlicht: (2008-12-01)

Not first‐line antihypertensive agents, but still effective—The efficacy and safety of imidazoline receptor agonists: A network meta‐analysis
von: András Érszegi, et al.
Veröffentlicht: (2024-06-01)

Cerebral blood flow and blood rheology in hypertensive patients during rilmenidine treatment
von: L. I. Markova, et al.
Veröffentlicht: (2004-06-01)

BISOPROLOL AND METFORMIN IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC SYNDROME
von: V. A. Nevzorova, et al.
Veröffentlicht: (2015-12-01)

Prevalence of metabolic syndrome and its components in patients with arterial hypertension and obesity
von: I. E. Chazova, et al.
Veröffentlicht: (2005-12-01)

Valsartan effects on platelet activity in patients with arterial hypertension and metabolic syndrom
von: I. N. Medvedev, et al.
Veröffentlicht: (2007-06-01)

Reduced platelet aggregation in losartan-treated patients with arterial hypertension and metabolic syndrome
von: I. N. Medvedev, et al.
Veröffentlicht: (2008-10-01)

Eprosartan effects on intravascular platelet activity in patients with arterial hypertension and metabolic syndrome
von: I. N. Medvedev, et al.
Veröffentlicht: (2008-02-01)

Intravascular platelet activity correction by fosinopril in arterial hypertension patients with metabolic syndrome
von: I. N. Medvedev, et al.
Veröffentlicht: (2006-10-01)

Microcirculatory function in patients with arterial hypertension, metabolic syndrome and diabetes mellitus
von: A. P. Vasilyev, et al.
Veröffentlicht: (2008-10-01)

Some hormonal systems in males with arterial hypertension and metabolic syndrome
von: A. N. Britov, et al.
Veröffentlicht: (2006-06-01)

Metabolic syndrome in patients with arterial hypertension living in the Far North (on the example of the Khanty-Mansi Autonomous Okrug — Yugra)
von: E. G. Ivanova, et al.
Veröffentlicht: (2023-04-01)

CORRECTION OF AGGREGATIVE FUNCTION OF THE TROMBOCYTES IN ARTERIAL HYPERTENSION PATIENTS WITH METABOLIC SYNDROM UNDER THE INFLUENCE OF SIMVASTATINE
von: N. J. Gromnazky, et al.
Veröffentlicht: (2003-12-01)

The comorbid patients with arterial hypertension, chronic heart failure and chronic kidney disease: the role of fosinoprile
von: G. N. Gorokhovskaya, et al.
Veröffentlicht: (2018-04-01)

Arterial hypertension and metabolic syndrome: specifics of antihypertensive therapy
von: L. I. Abasova, et al.
Veröffentlicht: (2011-08-01)

Features of the clinical course of arterial hypertension in alien residents of Western Siberia with the establishment of patterns of metabolic changes
von: E. G. Ivanova, et al.
Veröffentlicht: (2022-07-01)

Spirapril effects on heart remodeling in patients with mild to moderate arterial hypertension
von: M. M. Beraya, et al.
Veröffentlicht: (2007-02-01)

Pathogenesis of arterial hypertension within the metabolic syndrome
von: A S Ryazanov, et al.
Veröffentlicht: (2003-03-01)

Antihypertensive spirapril effectiveness in patients with mild to moderate arterial hypertension
von: M. M. Beraya, et al.
Veröffentlicht: (1970-01-01)

Imidazoline receptor agonist moxonidine and arterial hypertension treatment in women with menopausal metabolic syndrome
von: E. V. Tishina, et al.
Veröffentlicht: (2011-06-01)

Moxonidine for arterial hypertension treatment in menopausal women with metabolic syndrome
von: V. V. Trusov, et al.
Veröffentlicht: (2007-08-01)

AFFECTIVE DISORDERS IN MEN WITH ARTERIAL HYPERTENSION IN COMBINATION WITH METABOLIC SYNDROME
von: Roman A. Yaskevich, et al.
Veröffentlicht: (2022-08-01)

AFFECTIVE DISORDERS IN WOMEN WITH ARTERIAL HYPERTENSION IN COMBINATION WITH METABOLIC SYNDROME
von: Roman A. Yaskevich, et al.
Veröffentlicht: (2022-06-01)

SHIFTWORK AS ONE OF RISK FACTORS OF ARTERIAL HYPERTENSION AND METABOLIC DISORDERS
von: I. S. Dzherieva, et al.
Veröffentlicht: (2015-12-01)

The efficacy of available supplements and medical drugs in longevity medicine - a review
von: Michał Łata, et al.
Veröffentlicht: (2025-01-01)